August 1, 2008 - Indiana University has executed an agreement with Western Institutional Review Board (WIRB), commercial, or external IRB. WIRB’s services are available to Indianapolis researchers who are conducting phase II, III, or IV industry-sponsored clinical trials not involving planned emergency research, xenotransplantation, gene transfer, embryonic stem cells, VA facilities or patients, medical devices, a pediatric population, or waivers of informed consent or authorization.
The application process, training and roll-out are in development. Currently, regulatory matters such as updating federal wide assurances and new standard operating procedures are in the works. These must be completed before the services of WIRB may be offered. Research Compliance Administration (RCA) is very excited about WIRB and sees it as a great complement to the University’s Human Research Protection Programs. It is anticipated that the services of WIRB may be offered to IUPUI investigators later this summer.